Molecular Basis Underlying Hepatobiliary and Renal Excretion of Phenolic Acids of Salvia miltiorrhiza Roots (Danshen)
暂无分享,去创建一个
X. Long | Xuefeng Zeng | Weiwei Jia | Jun-ling Yang | Chuan Li | Xin Zhou | Olajide E. Olaleye | Feng-qing Wang | Jiajia Dong | L. Ren | Jun-lan Lu | Yanmin Zhu | Nan-nan Tian
[1] Jun Liu,et al. Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial , 2021, Signal Transduction and Targeted Therapy.
[2] Yanhong Shi,et al. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule , 2021, Acta Pharmacologica Sinica.
[3] H. Lee,et al. Involvement of Organic Anion Transporters in the Pharmacokinetics and Drug Interaction of Rosmarinic Acid , 2021, Pharmaceutics.
[4] Yu-hong Huang,et al. Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions , 2019, Acta Pharmacologica Sinica.
[5] Jie Ren,et al. Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications , 2019, Front. Pharmacol..
[6] Songqiao Liu,et al. High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care , 2019, Acta pharmaceutica Sinica. B.
[7] P. Little,et al. Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential. , 2019, Pharmacological research.
[8] Jian Zhou,et al. Transport of salvianolic acid B via the human organic anion transporter 1B1 in the liver , 2018, Phytotherapy research : PTR.
[9] Wei Niu,et al. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions , 2018, Acta Pharmacologica Sinica.
[10] Chuang Lu,et al. Glycyrrhizin has a high likelihood to be a victim of drug–drug interactions mediated by hepatic organic anion‐transporting polypeptide 1B1/1B3 , 2018, British journal of pharmacology.
[11] Yanhong Shi,et al. Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides from XueBiJing, a Chinese Herbal Injection Used in Sepsis Management , 2018, Drug Metabolism and Disposition.
[12] Peiqing Liu,et al. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics , 2018, Acta Pharmacologica Sinica.
[13] Chuan Li. [Multi-compound pharmacokinetic research on Chinese herbal medicines: approach and methodology]. , 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[14] J. Sahi,et al. Role of Hepatic Drug Transporters in Drug Development , 2016, Journal of clinical pharmacology.
[15] P. Marathe,et al. Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression , 2015, Drug Metabolism and Disposition.
[16] Rongrong Jiang,et al. Renal Tubular Secretion of Tanshinol: Molecular Mechanisms, Impact on Its Systemic Exposure, and Propensity for Dose-Related Nephrotoxicity and for Renal Herb-Drug Interactions , 2015, Drug Metabolism and Disposition.
[17] Bu-chang Zhao,et al. Systemic Exposure to and Disposition of Catechols Derived from Salvia miltiorrhiza Roots (Danshen) after Intravenous Dosing DanHong Injection in Human Subjects, Rats, and Dogs , 2015, Drug Metabolism and Disposition.
[18] Li-Hong Hu,et al. Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen) , 2015, Acta Pharmacologica Sinica.
[19] Q. Meng,et al. Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. , 2015, Current drug metabolism.
[20] Rongrong Jiang,et al. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside‐perpetrated herb–drug interactions on OATP1B3 , 2015, British journal of pharmacology.
[21] K. Giacomini,et al. Renal transporters in drug development. , 2013, Annual review of pharmacology and toxicology.
[22] Marilyn E. Morris,et al. Prediction of Biliary Excretion in Rats and Humans Using Molecular Weight and Quantitative Structure–Pharmacokinetic Relationships , 2009, The AAPS Journal.
[23] Xiumei Gao,et al. Plasma and Urinary Tanshinol from Salvia miltiorrhiza (Danshen) Can Be Used as Pharmacokinetic Markers for Cardiotonic Pills, a Cardiovascular Herbal Medicine , 2008, Drug Metabolism and Disposition.
[24] A. Y. Lu,et al. Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.
[25] R. T. Williams,et al. Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: molecular weight, polarity and metabolism as factors in biliary excretion. , 1967, The Biochemical journal.
[26] K. Woo,et al. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. , 2005, Current medicinal chemistry.
[27] R. Smith,et al. Excretion of Drugs in Bile , 1971 .
[28] P. Millburn. FACTORS IN THE BILIARY EXCRETION OF ORGANIC COMPOUNDS , 1970 .